Cargando…
Clinical and Molecular Heterogeneity of RTEL1 Deficiency
Typical features of dyskeratosis congenita (DC) resulting from excessive telomere shortening include bone marrow failure (BMF), mucosal fragility, and pulmonary or liver fibrosis. In more severe cases, immune deficiency and recurring infections can add to disease severity. RTEL1 deficiency has recen...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410638/ https://www.ncbi.nlm.nih.gov/pubmed/28507545 http://dx.doi.org/10.3389/fimmu.2017.00449 |
_version_ | 1783232723521896448 |
---|---|
author | Speckmann, Carsten Sahoo, Sushree Sangita Rizzi, Marta Hirabayashi, Shinsuke Karow, Axel Serwas, Nina Kathrin Hoemberg, Marc Damatova, Natalja Schindler, Detlev Vannier, Jean-Baptiste Boulton, Simon J. Pannicke, Ulrich Göhring, Gudrun Thomay, Kathrin Verdu-Amoros, J. J. Hauch, Holger Woessmann, Wilhelm Escherich, Gabriele Laack, Eckart Rindle, Liliana Seidl, Maximilian Rensing-Ehl, Anne Lausch, Ekkehart Jandrasits, Christine Strahm, Brigitte Schwarz, Klaus Ehl, Stephan R. Niemeyer, Charlotte Boztug, Kaan Wlodarski, Marcin W. |
author_facet | Speckmann, Carsten Sahoo, Sushree Sangita Rizzi, Marta Hirabayashi, Shinsuke Karow, Axel Serwas, Nina Kathrin Hoemberg, Marc Damatova, Natalja Schindler, Detlev Vannier, Jean-Baptiste Boulton, Simon J. Pannicke, Ulrich Göhring, Gudrun Thomay, Kathrin Verdu-Amoros, J. J. Hauch, Holger Woessmann, Wilhelm Escherich, Gabriele Laack, Eckart Rindle, Liliana Seidl, Maximilian Rensing-Ehl, Anne Lausch, Ekkehart Jandrasits, Christine Strahm, Brigitte Schwarz, Klaus Ehl, Stephan R. Niemeyer, Charlotte Boztug, Kaan Wlodarski, Marcin W. |
author_sort | Speckmann, Carsten |
collection | PubMed |
description | Typical features of dyskeratosis congenita (DC) resulting from excessive telomere shortening include bone marrow failure (BMF), mucosal fragility, and pulmonary or liver fibrosis. In more severe cases, immune deficiency and recurring infections can add to disease severity. RTEL1 deficiency has recently been described as a major genetic etiology, but the molecular basis and clinical consequences of RTEL1-associated DC are incompletely characterized. We report our observations in a cohort of six patients: five with novel biallelic RTEL1 mutations p.Trp456Cys, p.Ile425Thr, p.Cys1244ProfsX17, p.Pro884_Gln885ins53X13, and one with novel heterozygous mutation p.Val796AlafsX4. The most unifying features were hypocellular BMF in 6/6 and B-/NK-cell lymphopenia in 5/6 patients. In addition, three patients with homozygous mutations p.Trp456Cys or p.Ile425Thr also suffered from immunodeficiency, cerebellar hypoplasia, and enteropathy, consistent with Hoyeraal-Hreidarsson syndrome. Chromosomal breakage resembling a homologous recombination defect was detected in patient-derived fibroblasts but not in hematopoietic compartment. Notably, in both cellular compartments, differential expression of 1243aa and 1219/1300aa RTEL1 isoforms was observed. In fibroblasts, response to ionizing irradiation and non-homologous end joining were not impaired. Telomeric circles did not accumulate in patient-derived primary cells and lymphoblastoid cell lines, implying alternative pathomechanisms for telomeric loss. Overall, RTEL1-deficient cells exhibited a phenotype of replicative exhaustion, spontaneous apoptosis and senescence. Specifically, CD34(+) cells failed to expand in vitro, B-cell development was compromised, and T-cells did not proliferate in long-term culture. Finally, we report on the natural history and outcome of our patients. While two patients died from infections, hematopoietic stem cell transplantation (HSCT) resulted in sustained engraftment in two patients. Whether chemotherapy negatively impacts on the course and onset of other DC-related symptoms remains open at present. Early-onset lung disease occurred in one of our patients after HSCT. In conclusion, RTEL deficiency can show a heterogeneous clinical picture ranging from mild hypocellular BMF with B/NK cell lymphopenia to early-onset, very severe, and rapidly progressing cellular deficiency. |
format | Online Article Text |
id | pubmed-5410638 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-54106382017-05-15 Clinical and Molecular Heterogeneity of RTEL1 Deficiency Speckmann, Carsten Sahoo, Sushree Sangita Rizzi, Marta Hirabayashi, Shinsuke Karow, Axel Serwas, Nina Kathrin Hoemberg, Marc Damatova, Natalja Schindler, Detlev Vannier, Jean-Baptiste Boulton, Simon J. Pannicke, Ulrich Göhring, Gudrun Thomay, Kathrin Verdu-Amoros, J. J. Hauch, Holger Woessmann, Wilhelm Escherich, Gabriele Laack, Eckart Rindle, Liliana Seidl, Maximilian Rensing-Ehl, Anne Lausch, Ekkehart Jandrasits, Christine Strahm, Brigitte Schwarz, Klaus Ehl, Stephan R. Niemeyer, Charlotte Boztug, Kaan Wlodarski, Marcin W. Front Immunol Immunology Typical features of dyskeratosis congenita (DC) resulting from excessive telomere shortening include bone marrow failure (BMF), mucosal fragility, and pulmonary or liver fibrosis. In more severe cases, immune deficiency and recurring infections can add to disease severity. RTEL1 deficiency has recently been described as a major genetic etiology, but the molecular basis and clinical consequences of RTEL1-associated DC are incompletely characterized. We report our observations in a cohort of six patients: five with novel biallelic RTEL1 mutations p.Trp456Cys, p.Ile425Thr, p.Cys1244ProfsX17, p.Pro884_Gln885ins53X13, and one with novel heterozygous mutation p.Val796AlafsX4. The most unifying features were hypocellular BMF in 6/6 and B-/NK-cell lymphopenia in 5/6 patients. In addition, three patients with homozygous mutations p.Trp456Cys or p.Ile425Thr also suffered from immunodeficiency, cerebellar hypoplasia, and enteropathy, consistent with Hoyeraal-Hreidarsson syndrome. Chromosomal breakage resembling a homologous recombination defect was detected in patient-derived fibroblasts but not in hematopoietic compartment. Notably, in both cellular compartments, differential expression of 1243aa and 1219/1300aa RTEL1 isoforms was observed. In fibroblasts, response to ionizing irradiation and non-homologous end joining were not impaired. Telomeric circles did not accumulate in patient-derived primary cells and lymphoblastoid cell lines, implying alternative pathomechanisms for telomeric loss. Overall, RTEL1-deficient cells exhibited a phenotype of replicative exhaustion, spontaneous apoptosis and senescence. Specifically, CD34(+) cells failed to expand in vitro, B-cell development was compromised, and T-cells did not proliferate in long-term culture. Finally, we report on the natural history and outcome of our patients. While two patients died from infections, hematopoietic stem cell transplantation (HSCT) resulted in sustained engraftment in two patients. Whether chemotherapy negatively impacts on the course and onset of other DC-related symptoms remains open at present. Early-onset lung disease occurred in one of our patients after HSCT. In conclusion, RTEL deficiency can show a heterogeneous clinical picture ranging from mild hypocellular BMF with B/NK cell lymphopenia to early-onset, very severe, and rapidly progressing cellular deficiency. Frontiers Media S.A. 2017-05-01 /pmc/articles/PMC5410638/ /pubmed/28507545 http://dx.doi.org/10.3389/fimmu.2017.00449 Text en Copyright © 2017 Speckmann, Sahoo, Rizzi, Hirabayashi, Karow, Serwas, Hoemberg, Damatova, Schindler, Vannier, Boulton, Pannicke, Göhring, Thomay, Verdu-Amoros, Hauch, Woessmann, Escherich, Laack, Rindle, Seidl, Rensing-Ehl, Lausch, Jandrasits, Strahm, Schwarz, Ehl, Niemeyer, Boztug and Wlodarski. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Speckmann, Carsten Sahoo, Sushree Sangita Rizzi, Marta Hirabayashi, Shinsuke Karow, Axel Serwas, Nina Kathrin Hoemberg, Marc Damatova, Natalja Schindler, Detlev Vannier, Jean-Baptiste Boulton, Simon J. Pannicke, Ulrich Göhring, Gudrun Thomay, Kathrin Verdu-Amoros, J. J. Hauch, Holger Woessmann, Wilhelm Escherich, Gabriele Laack, Eckart Rindle, Liliana Seidl, Maximilian Rensing-Ehl, Anne Lausch, Ekkehart Jandrasits, Christine Strahm, Brigitte Schwarz, Klaus Ehl, Stephan R. Niemeyer, Charlotte Boztug, Kaan Wlodarski, Marcin W. Clinical and Molecular Heterogeneity of RTEL1 Deficiency |
title | Clinical and Molecular Heterogeneity of RTEL1 Deficiency |
title_full | Clinical and Molecular Heterogeneity of RTEL1 Deficiency |
title_fullStr | Clinical and Molecular Heterogeneity of RTEL1 Deficiency |
title_full_unstemmed | Clinical and Molecular Heterogeneity of RTEL1 Deficiency |
title_short | Clinical and Molecular Heterogeneity of RTEL1 Deficiency |
title_sort | clinical and molecular heterogeneity of rtel1 deficiency |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410638/ https://www.ncbi.nlm.nih.gov/pubmed/28507545 http://dx.doi.org/10.3389/fimmu.2017.00449 |
work_keys_str_mv | AT speckmanncarsten clinicalandmolecularheterogeneityofrtel1deficiency AT sahoosushreesangita clinicalandmolecularheterogeneityofrtel1deficiency AT rizzimarta clinicalandmolecularheterogeneityofrtel1deficiency AT hirabayashishinsuke clinicalandmolecularheterogeneityofrtel1deficiency AT karowaxel clinicalandmolecularheterogeneityofrtel1deficiency AT serwasninakathrin clinicalandmolecularheterogeneityofrtel1deficiency AT hoembergmarc clinicalandmolecularheterogeneityofrtel1deficiency AT damatovanatalja clinicalandmolecularheterogeneityofrtel1deficiency AT schindlerdetlev clinicalandmolecularheterogeneityofrtel1deficiency AT vannierjeanbaptiste clinicalandmolecularheterogeneityofrtel1deficiency AT boultonsimonj clinicalandmolecularheterogeneityofrtel1deficiency AT pannickeulrich clinicalandmolecularheterogeneityofrtel1deficiency AT gohringgudrun clinicalandmolecularheterogeneityofrtel1deficiency AT thomaykathrin clinicalandmolecularheterogeneityofrtel1deficiency AT verduamorosjj clinicalandmolecularheterogeneityofrtel1deficiency AT hauchholger clinicalandmolecularheterogeneityofrtel1deficiency AT woessmannwilhelm clinicalandmolecularheterogeneityofrtel1deficiency AT escherichgabriele clinicalandmolecularheterogeneityofrtel1deficiency AT laackeckart clinicalandmolecularheterogeneityofrtel1deficiency AT rindleliliana clinicalandmolecularheterogeneityofrtel1deficiency AT seidlmaximilian clinicalandmolecularheterogeneityofrtel1deficiency AT rensingehlanne clinicalandmolecularheterogeneityofrtel1deficiency AT lauschekkehart clinicalandmolecularheterogeneityofrtel1deficiency AT jandrasitschristine clinicalandmolecularheterogeneityofrtel1deficiency AT strahmbrigitte clinicalandmolecularheterogeneityofrtel1deficiency AT schwarzklaus clinicalandmolecularheterogeneityofrtel1deficiency AT ehlstephanr clinicalandmolecularheterogeneityofrtel1deficiency AT niemeyercharlotte clinicalandmolecularheterogeneityofrtel1deficiency AT boztugkaan clinicalandmolecularheterogeneityofrtel1deficiency AT wlodarskimarcinw clinicalandmolecularheterogeneityofrtel1deficiency |